Delivery Order SPE2DB25D3012-SPE2DB25FWYKC
Award Date
7/3/25
Potential Completion Date
7/7/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of pharmaceutical products, including dapagliflozin-metformin extended-release tablets, with a ceiling value of $1,406.04 and a performance period through May 2, 2025. The contract is not set aside and was competed openly. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,464.90, is for the delivery of 4564986974 - Dapagliflozin 10 mg tablets in 30-count packages. The contract has a firm fixed price and is set to expire on June 25, 2024. This order is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a $4,788.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dapagliflozin-Metformin ER 5-1000 mg tablets, with a performance period through July 2025. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,396.00 delivery order is for the supply of 4,564,766,189 units of the prescription medication Dapagliflozin 10 mg tablets. The contract has a firm-fixed price and is not set aside for any specific business category. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,468,045 units of the pharmaceutical product Dapagliflozin 10 mg Tablets. The contract has a ceiling value of $13,780.10 and an ultimate completion date of August 16, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,762.40, is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of March 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a $1,111.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,908,355 units of the drug dapagliflozin 10 mg tablets in 30-count packages. The contract has an ultimate completion date of April 15, 2025 and was awarded on April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,232,835 units of the pharmaceutical drug dapagliflozin 10 mg tablet in 30-count packages. The award has a ceiling value of $1,202.59 and a period of performance through May 14, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor, for the supply of dapagliflozin 10 mg tablets. The contract is a firm fixed-price agreement with a ceiling value of $1,614.94 and a period of performance through July 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, valued up to $999,999,999, for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dapagliflozin 10 mg tablets in 30-count packages, with a ceiling value of $1,187.05 and a period of performance through April 14, 2025. The contract was awarded on a firm-fixed price basis and was not set aside for any specific business category. AmerisourceBergen holds a...